Mithra and Fuji Pharma to commence Estelle ’s PK trial in ASEAN markets

Belgium-based Mithra Pharmaceuticals and Japan's Fuji Pharma are set to begin a pharmacokinetic (PK) ethnobridging trial of Estelle in Japanese and Caucasian women.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Women